Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NNNN | DNTH | KNSA | ||
| Company | Anbio Biotechnology Cl A | Dianthus Therapeutics Inc | Kiniksa Pharmaceuticals International Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 25.80 | 83.92 | 48.78 | ||
| High | 26.52 | 83.92 | 48.78 | ||
| Low | 23.22 | 83.92 | 48.78 | ||
| Latest | 25.69 | 83.92 | 48.78 | ||
| Change | +1.08 | unch | +0.63 | ||
| % Change | +4.39% | unch | +1.31% | ||
| Volume | 21,200 | 1,543 | 581 | ||
| 20-Day Average Volume | 34,460 | 1,577,817 | 618,429 | ||
| Previous Close | 24.61 | 83.92 | 48.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.68 | 78.93 | 46.32 | ||
| 20-Day Raw Stochastic | 75.64% | 85.66% | 100.00% | ||
| 20-Day Relative Strength | 53.02 | 68.95 | 60.15 | ||
| Weighted Alpha | -20.70 | +395.32 | +110.69 | ||
| Today's Opinion | 64% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 72% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.78% since 03/24/26 | +5.41% since 03/25/26 | +6.41% since 03/25/26 | ||
| Low | 22.18 on 03/25/26 | 77.64 on 03/31/26 | 44.76 on 03/30/26 | ||
| High | 27.49 on 03/30/26 | 86.25 on 03/31/26 | 48.78 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -0.27% since 02/27/26 | +52.06% since 02/27/26 | +9.64% since 02/27/26 | ||
| Low | 20.10 on 03/13/26 | 52.07 on 03/03/26 | 43.33 on 03/04/26 | ||
| High | 27.49 on 03/30/26 | 88.02 on 03/11/26 | 48.78 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | -23.31% since 12/26/25 | +103.64% since 12/31/25 | +18.25% since 12/31/25 | ||
| Low | 18.50 on 01/27/26 | 35.84 on 01/06/26 | 37.02 on 01/15/26 | ||
| High | 44.44 on 01/29/26 | 88.02 on 03/11/26 | 49.12 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | -26.47% since 09/26/25 | +115.57% since 10/01/25 | +26.24% since 10/01/25 | ||
| Low | 10.50 on 11/04/25 | 32.22 on 10/23/25 | 35.20 on 10/28/25 | ||
| High | 51.33 on 10/03/25 | 88.02 on 03/11/26 | 49.12 on 02/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,696,560 | 3,732,006 | 3,685,161 | ||
| Shares Outstanding, K | 143,891 | 44,471 | 76,535 | ||
| Annual Sales | 8,190,000 | 2,040,000 | 677,560,000 | ||
| Annual Net Income | 2,370,000 | -162,340,000 | 59,010,000 | ||
| Last Quarter Sales | N/A | 280,000 | 202,130,000 | ||
| Last Quarter Net Income | N/A | -64,430,000 | 14,200,000 | ||
| 60-Month Beta | N/A | 1.56 | 0.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.43 on 03/09/26 | 0.17 on 02/24/26 | ||
| Latest Earnings Date | N/A | 05/11/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 61.76 | ||